Skip to main content
Fig. 5 | Journal of Translational Medicine

Fig. 5

From: PTEN deficiency potentiates HBV-associated liver cancer development through augmented GP73/GOLM1

Fig. 5

GP73 knockout blocks tumor development of HBV; Pten−/− mice. A Immunoblotting analysis of 4-month-old WT, HBV, Pten−/−, and HBV; Pten−/− livers (upper panel) and tumors and adjacent liver tissues from 9-month-old HBV; Pten−/− mice (lower panel). T: tumor, N: adjacent tissues. B–D 9-month-old HBV; Pten−/− and HBV; Pten−/−; Gp73−/− mice. B The ratio of liver weight to body weight of mice (n = 15). C Representative images of livers. D Number (> 3 mm) and maximal size of liver tumors (n = 15). E Immunoblotting analysis of GP73 and cleaved-caspase 3 of 4-month-old HBV; Pten−/− and HBV; Pten−/−; Gp73−/− livers. F Masson’s trichrome, CD34 and Cleaved Caspase 3 staining of 9-month-old HBV; Pten−/− and HBV; Pten−/−; Gp73−/− livers. G Serum ALT and AST of 4-month-old HBV; Pten−/− and HBV; Pten−/−; Gp73−/− mice (n = 10–11). H Immunoblotting analysis of 4-month-old HBV; Pten−/− and HBV; Pten−/−; Gp73−/− livers. I qRT-PCR analysis of IL6 mRNA level in 4-month-old HBV; Pten−/− and HBV; Pten−/−; Gp73.−/− livers (n = 10). Scale bar, 100 μm. Data were shown as mean ± SD, **p < 0.01, ***p < 0.001

Back to article page